Access the full text.
Sign up today, get DeepDyve free for 14 days.
Sarah E. Nagler Gollust (2020)
The Emergence of COVID-19 in the US: A Public Health and Political Communication CrisisJournal of Health Politics, Policy and Law, 45
(2020)
Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19New England Journal of Medicine
Caleb P. Pastick Skipper (2020)
Hydroxychloroquine in Nonhospitalized Adults with Early COVID-19: A Randomized TrialAnnals of Internal Medicine, 173
Eitan D. Goldenberg Hersh (2016)
Democratic and Republican Physicians Provide Different Care on Politicized Health IssuesProceedings of the National Academy of Sciences, 113
Adrian V. Roman Hernandez (2020b)
Update Alert: Hydroxychloroquine or Chloroquine for the Treatment or Prophylaxis of COVID-19Annals of Internal Medicine, 173
Alexandre B. Zampieri Cavalcanti (2020)
Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19New England Journal of Medicine, 383
Biot (2006)
2845Journal of Medicinal Chemistry, 49
DOH Hawaii (2020)
COVID-19 Daily Update March 23, 2020
(2020b)
Laura's Hydroxychloroquine Push Now Seems PrescientThe Ingraham Angle
Aaron Blake (2020)
Fox News and Trump Are Still Pushing Hydroxychloroquine. Here's What the Data Actually ShowsWashington Post
Sheera Alba Frenkel (2020)
Misleading Virus Video, Pushed by the Trumps, Spreads OnlineNew York Times
Wei Cao Tang (2020)
Hydroxychloroquine in Patients with Mainly Mild to Moderate Coronavirus Disease 2019: Open Label, Randomised Controlled TrialBMJ
Arshad (2020)
396International Journal of Infectious Diseases, 97
Michael M. Grynbaum (2020)
Fox News Stars Trumpeted a Malaria Drug, until They Didn'tNew York Times
Vijay Chobufo Gayam (2020)
Clinical Characteristics and Predictors of Mortality in African‐Americans with COVID‐19 from an Inner‐City Community Teaching Hospital in New YorkJournal of Medical Virology, 93
Jun Liu Chen (2020)
A Pilot Study of Hydroxychloroquine in Treatment of Patients with Moderate COVID-19Journal of Zhejiang University (Medical Sciences), 49
(2020b)
Fact Sheet for Health Care Providers: Emergency Use Authorization (EUA) of Hydroxychloroquine Sulfate Supplied from the Strategic National Stockpile for Treatment of COVID-19 in Certain Hospitalized Patients
(2020a)
Coronavirus (COVID-19) Update: FDA Revokes Emergency Use Authorization for Chloroquine and Hydroxychloroquine
Kathleen Hall Albarracin Jamieson (2020)
The Relation between Media Consumption and Misinformation at the Outset of the SARS-CoV-2 Pandemic in the USHarvard Kennedy School Misinformation Review
Samia Kilgore Arshad (2020)
Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19International Journal of Infectious Diseases, 97
(2020a)
New Study Reveals Anti-Viral Medication May Be Highly Effective at Treating CoronavirusThe Ingraham Angle
Michael Caputi Liu (2020)
Internet Searches for Unproven COVID-19 Therapies in the United StatesJAMA Internal Medicine, 180
Marisa Roston Taylor (2020)
Exclusive: Pressed by Trump, US Pushed Unproven Coronavirus Treatment Guidance
Botero Maria Ronderos (2020)
COVID-19 in the Healthy Patient Population: Demographic and Clinical Phenotypic Characterization and Predictors of In-Hospital OutcomesArteriosclerosis, Thrombosis, and Vascular Biology, 40
Adrian V. Roman Hernandez (2020a)
Hydroxychloroquine or Chloroquine for Treatment or Prophylaxis of COVID-19: A Living Systematic ReviewAnnals of Internal Medicine, 173
Priyank Owens Shah (2020)
Demographics, Comorbidities, and Outcomes in Hospitalized Covid-19 Patients in Rural Southwest GeorgiaAnnals of Medicine, 52
Adam Rosenthal Bonica (2020)
Ideological Sorting of Physicians in Both Geography and the WorkplaceJournal of Health Politics, Policy and Law, 45
Joshua Cohen Clinton (2021)
Partisan Pandemic: How Partisanship and Public Health Concerns Affect Individuals' Social Mobility during COVID-19Science Advances, 7
Annie Thomas Karni (2020)
Trump Says He's Taking Hydroxychloroquine, Prompting Warning from Health ExpertsNew York Times
Lara Gray Bull-Otterson (2020)
Hydroxychloroquine and Chloroquine Prescribing Patterns by Provider Specialty following Initial Reports of Potential Benefit for COVID-19 Treatment—United States, January–June 2020Morbidity and Mortality Weekly Report, 69
Matt Stecula Motta (2020)
How Right-Leaning Media Coverage of COVID-19 Facilitated the Spread of Misinformation in the Early Stages of the Pandemic in the USCanadian Journal of Political Science, 53
Shana Kushner Goodman Gadarian (2021)
Partisanship, Health Behavior, and Policy Attitudes in the Early Stages of the COVID-19 PandemicPLOS One, 16
(2020a)
Americans Grow Anxious about Coronavirus PandemicTucker Carlson Tonight
G. Caleb Tajanlangit Alexander (2020)
Use and Content of Primary Care Office-Based vs. Telemedicine Care Visits during the COVID-19 Pandemic in the USJAMA Network Open, 3
Alexander (2020)
e2021476JAMA Network Open, 3
Lev Facher (2020)
Debate over Hydroxychloroquine Spills over from the White House to Congressional CampaignsStat News
Peter Mafham Horby (2020)
Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19: Preliminary Results from a Multi-Centre, Randomized, Controlled Trial
Jörg L. Toniatti Spenkuch (2016)
Political Advertising and Election Outcomes
Jeffrey Layne Edgerton Blevins (2021)
Shouting into the Wind: Medical Science versus ‘BS’ in the Twitter Maelstrom of Politics and Misinformation about HydroxychloroquineSocial Media + Society
Sarah Owermohle (2020)
FDA Struggles to Remain Independent amid Race for Virus Cure
(2020b)
Study Suggests Malaria Drug Can Treat CoronavirusTucker Carlson Tonight
Xueting Ye Yao (2020)
In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)Clinical Infectious Diseases, 71
Christophe Daher Biot (2006)
Design and Synthesis of Hydroxyferroquine Derivatives with Antimalarial and Antiviral ActivitiesJournal of Medicinal Chemistry, 49
Philippe Lagier Gautret (2020)
Hydroxychloroquine and Azithromycin as a Treatment of COVID-19: Results of an Open-Label Non-Randomized Clinical TrialInternational Journal of Antimicrobial Agents, 56
James J. Hubbard Harrigan (2020)
Association between US Administration Endorsement of Hydroxychloroquine for COVID-19 and Outpatient PrescribingJournal of General Internal Medicine, 35
Ellen Keller Gabler (2020)
Prescriptions Surged as Trump Praised Drugs in Coronavirus FightNew York Times
Julia Carrie Wong (2020)
Hydroxychloroquine: How an Unproven Drug Became Trump's Coronavirus ‘Miracle Cure.’Guardian
Gregory J. Yurukoglu Martin (2017)
Bias in Cable News: Persuasion and PolarizationAmerican Economic Review, 107
Denise M. Hinton (2020)
Re: Request for Emergency Use Authorization for Use of Chloroquine Phosphate or Hydroxychloroquine Sulfate Supplied from the Strategic National Stockpile for Treatment of 2019 Coronavirus Disease
Donald Trump (2020)
Remarks by President Trump, Vice President Pence, and Members of the Coronavirus Task Force in Press Briefing
Laura Y. Hersh Zatz (2020)
Physicians' Political Party Affiliation and Clinical Management of ObesityClinical Obesity, 10
Manli Cao Wang (2020)
Remdesivir and Chloroquine Effectively Inhibit the Recently Emerged Novel Coronavirus (2019-nCoV) in VitroCell Research, 30
Nadine Lovegrove Shehab (2020)
US Hydroxychloroquine, Chloroquine, and Azithromycin Outpatient Prescription Trends, October 2019 through March 2020JAMA Internal Medicine, 180
David R. Pullen Boulware (2020)
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19New England Journal of Medicine, 383
Context: On March 19, 2020, President Donald Trump endorsed using hydroxychloroquine for COVID-19 treatment despite inconclusive evidence of the drug's effectiveness. This study sought to understand the influence of political preferences on prescription uptake by quantifying the relationship between a geographic area's partisan leaning and hydroxychloroquine prescription rates following Trump's endorsement. Methods: We analyzed hydroxychloroquine prescriptions filled in 205 continental US designated market areas (DMAs) between March 1, 2018, and July 31, 2020, and the percentage of votes for Donald Trump in the 2016 presidential election in each DMA. We estimated associations by using an empirical strategy resembling a difference-in-differences estimation. Findings: Before President Trump's endorsement, mean weekly hydroxychloroquine prescription rates were similar across DMAs with the highest and lowest Trump vote percentages (0.56 and 0.49 scripts per 100,000). After Trump's endorsement, although both high- and low-Trump-supportive DMAs experienced sharp increases in weekly hydroxychloroquine prescription rates, results indicated a 1-percentage-point increase in share of Trump votes was associated with 0.013, or 2%, more weekly hydroxychloroquine prescriptions per 100,000 people (b = 0.013, t = 2.20, p = .028). Conclusion: President Trump's endorsement of an untested therapy influenced prescribing behavior, especially when that endorsement aligned with communities' political leanings.
Journal of Health Politics, Policy and Law – Duke University Press
Published: Aug 1, 2022
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.